Compare NVCR & LADR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVCR | LADR |
|---|---|---|
| Founded | 2000 | 2008 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2015 | 2013 |
| Metric | NVCR | LADR |
|---|---|---|
| Price | $12.16 | $10.21 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | ★ $28.08 | $12.25 |
| AVG Volume (30 Days) | 1.1M | ★ 1.1M |
| Earning Date | 04-30-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 8.94% |
| EPS Growth | ★ 21.79 | N/A |
| EPS | N/A | ★ 0.51 |
| Revenue | ★ $655,353,000.00 | N/A |
| Revenue This Year | $7.72 | $31.66 |
| Revenue Next Year | $6.74 | $16.92 |
| P/E Ratio | ★ N/A | $20.09 |
| Revenue Growth | ★ 8.28 | N/A |
| 52 Week Low | $9.82 | $9.61 |
| 52 Week High | $20.05 | $11.92 |
| Indicator | NVCR | LADR |
|---|---|---|
| Relative Strength Index (RSI) | 54.71 | 53.10 |
| Support Level | $10.72 | $9.92 |
| Resistance Level | $13.93 | $11.37 |
| Average True Range (ATR) | 0.53 | 0.19 |
| MACD | 0.25 | 0.06 |
| Stochastic Oscillator | 67.38 | 73.75 |
NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.
Ladder Capital Corp is an internally-managed real estate investment trust that is in commercial real estate finance. The company originates and invests in a diverse portfolio of commercial real estate and real estate-related assets, focusing on senior secured assets. The company's investment activities include: (i) Primary business of originating senior first mortgage fixed and floating rate loans collateralized by commercial real estate with flexible loan structures; (ii) owning and operating commercial real estate, including net leased commercial properties; and (iii) investing in investment-grade securities secured by first mortgage loans on commercial real estate. The company has three reportable segments: Loans, which derive maximum revenue; Securities; and Real Estate.